Clinical Trials Advisor is the one-stop resource for clinical research sponsors and sites investigating novel drugs and medical devices. Turn to CTA for timely information and advice on how to gain new business, improve operations and stay in compliance with the FDA’s GCP requirements. Each biweekly issue offers practical advice on maximizing your clinical investments, updates on the latest regulatory and international news, and more. Plus, it provides links to important documents — such as guidances, warning letters and Form 483s — from the FDA, foreign regulators and global organizations.

For two decades, Drug GMP Report has provided thorough analysis and interpretation of current good manufacturing practice (cGMP) regulations, FDA enforcement trends and warning letters, international regulations and more. It’s like receiving a monthly executive briefing packed with the latest on inspection hot spots, developments in international harmonization efforts, electronic data requirements and evolving trends in cGMP enforcement. Plus, every issue, you get links to critical documents such as draft and final guidances, Form 483s, warning letters, proposed rules, full text of proposed legislation and a host of others.

This daily electronic briefing delivers coverage of what’s happening on Capitol Hill and at the FDA, FTC, HHS and other key agencies and decision-making bodies that affect the pharmaceutical industry. Each issue gives you hard reporting on top issues, such as patent exclusivity, market globalization, biosimilar development, advertising, program funding, FDA appropriations, warning letters, recalls, approvals and more. Written by FDAnews’ veteran staff of reporters, you get the latest news with the added perspective that only seasoned reporters can provide. It’s the fastest, most reliable way to make sure you’re an industry expert.

International Devices & Diagnostics Monitor (IDDM) is a one-stop resource that brings you a complete, global picture of the medical device regulations that affect your business. Nowhere else will you find a more comprehensive collection of all the regulatory changes in the US, EU, Asia, Latin America, the Middle East, Australia and the rest of the world. Your subscription includes a weekly newsletter to keep you up to date with global regulations as changes happen, including complete text of all government documents.

For over 25 years, the Generic Line has been the leading resource for accurate, up-to-date analysis of FDA policies affecting generic drugs and drug patents. With a new biosimilars approval path, blockbuster drugs facing patent cliffs, and the FTC trying to stop pay-for-delay agreements, there's never been a more critical time to subscribe. With every issue, you get links to additional key documents, such as FDA guidances, warning letters, rules, full texts of proposed legislation and much more.

International Pharmaceutical Regulatory Monitor has been a ‘must read’ for pharma professionals for more than 40 years, bringing them the latest changes in rules and standards at the FDA, European Medicines Agency, Health Canada, Australia's TGA, International Conference on Harmonisation and other key organizations. And as the global marketplace has expanded to markets in Latin America, Asia and Africa, IPRM has kept readers informed of regulatory developments in those regions as well. In each issue, you get actual English-language texts of important, hard-to-obtain proposals, regulations, guidances and other documents to help ensure speedy reviews of your regulatory submissions and success at home and abroad.

For 30 years, medical device manufacturers worldwide have relied on The GMP Letter to comply with the FDA's interpretation and enforcement of cGMPs and the Quality System Regulation (QSR). In each issue, you get an update on regulations and guidances and learn which companies the FDA has inspected and what the audits revealed. You also get links to Form 483s, warning letters, closeout letters, FDA policy notices and many other reports to help make your quality assurance efforts a success.

Each day you'll receive targeted FDA regulatory, legislative and business news briefs in the pharmaceutical and biologics industries. Plus, you'll get a snapshot of international news relevant to your business. In just a few minutes you can scan major headlines and click through to read the stories you want. Sign up today and receive your first FDAnews Drug Daily Bulletin the next business day. This subscription includes a weekly email alert, FDAnews' Pharma Solution of the Week, highlighting one problem and one solution in the pharmaceutical arena.

Each day you'll receive targeted FDA regulatory, legislative and business news briefs in the pharmaceutical and biologics industries. Plus, you'll get a snapshot of international news relevant to your business. In just a few minutes you can scan major headlines and click through to read the stories you want. Sign up today and receive your first FDAnews Drug Daily Bulletin the next business day. This subscription includes a weekly email alert, FDAnews' Pharma Solution of the Week, highlighting one problem and one solution in the pharmaceutical arena.

By reading the Quality Management Network's QMN Weekly Bulletin you can keep track of the latest from the FDA, Congress and industry experts in the world of cGMP's for pharmaceutical and medical device manufacturers. Each issue delivers crucial information on regulatory changes and inspection trends, as well as a wrap-up of the major quality management news from around the world. Sign up today and start receiving The QMN Weekly Bulletin.